from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun biochemistry A nucleotide-binding and leucin-rich protein which activates the inflammasome in response to toxins


Sorry, no etymologies found.


Help support Wordnik (and make this page ad-free) by adopting the word cryopyrin.


  • Ilaris treats cryopyrin-associated periodic syndrome, or CAPS, a rare, inherited disorder caused by a mutation in a single gene.

    FDA Approves a Novel Novartis Drug 2009

  • The concept of targeting the IL-1 pathway in some inflammatory diseases has been clinically validated by three FDA-approved therapies, one for rheumatoid arthritis, and two for cryopyrin-associated periodic syndromes (CAPS).

    News 2010

  • Background The cryopyrin-associated periodic syndrome (CAPS) is a rare inherited inflammatory disease associated with overproduction of interleukin-1.

    New England Journal of Medicine Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner 2009

  • When cryopyrin latches onto a foreign molecule that is part of an invading virus or bacterium, it activates other components of the innate immune response.

    unknown title 2009

  • Lachmann HJ, Lowe P, Felix SD et al. In vivo regulation of interleukin 1 in patients with cryopyrin-associated periodic syndromes.

    Presseportal 2009

  • Cryopyrin regulates the release of interleukin-1, an important mediator of fever and systemic inflammation during the body's innate immune response, and alterations in cryopyrin lead to over-production of Il-1.

    RxPG News : Latest Medical, Healthcare and Research News 2009

  • PhD, both of Immunology, and their colleagues explored further the in vivo role of the cryopyrin/caspase-1 machinery during influenza virus infection.

    unknown title 2009

  • The researchers discovered clues to how cryopyrin detects that the influenza virus has invaded an immune cell.

    unknown title 2009

  • In 2008, the FDA approved the second IL-1 drug, rilonacept, for cryopyrin-associated periodic syndromes (CAPS), providing additional regulatory support for the development of IL-1 therapeutics.

    News 2009

  • The findings about the cryopyrin machinery also have implications beyond influenza.

    unknown title 2009


Log in or sign up to get involved in the conversation. It's quick and easy.